Skip to content

NAFLD Study: US vs Liver Biopsy

Diagnostic Accuracy in a New Ultrasound Software Compared to Histology for Non Alcoholic Fatty Liver Disease (NAFLD) and Non Alcoholic Steato Hepatitis (NASH) in Morbidly Obese Individuals Undergoing Bariatic Surgery and/or Cholecystectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04101162
Acronym
NAFLD
Enrollment
20
Registered
2019-09-24
Start date
2019-09-15
Completion date
2020-12-15
Last updated
2020-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Alcoholic Fatty Liver Disease

Brief summary

Evaluate the diagnostic accuracy of the new ultrasound software vs hepatic histology, the current reference standard for the diagnosis of NAFLD and NASH in 20 obese patients (BMI\> 30) candidates for laparoscopic bariatric surgery and / or cholecystectomy

Interventions

DIAGNOSTIC_TESTshear waves elastography; liver biopsy

Diagnostic accuracy in a new ultrasound software compared to histology for Non Alcoholic Fatty liver disease (NAFLD) and Non Alcoholic Steato Hepatitis (NASH)

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients who are candidates for bariatric surgery between the ages of 18 and 65, * BMI\> 40 kg / m2, in the absence of any other comorbidity * BMI\> 35 kg / m2, in the presence of comorbidities among those classically considered to be associated with obesity * ICM\> 30 kg / m2, in the presence of T2DM not in glycometabolic compensation 2. Patients who are candidates for laparoscopic cholecystectomy for symptomatic calculi with BMI\> 30

Exclusion criteria

* Age ≤ 18 or ≥ 65 * Any concurrent surgical procedure except cholecystectomy and hiatal hernia repair * Conversion into laparotomy surgery * Post-operative complications requiring new surgical treatment * Patient not compliant in the follow-up

Design outcomes

Primary

MeasureTime frameDescription
diagnostic accurancy of ATI in obese patients6 monthsa new ultrasound software compared with liver biopsy in obese patients.

Countries

Italy

Contacts

Primary ContactANNA GUIDA, medicine
anna.guida88@gmail.com+393288699401

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026